English
中文版
Home
About us
Product
API R&D pipeline
Core Molecular Skeleton
Characteristic building blocks
Specialty chemicals
Original brand reagents
R&D Platform
News
Message
Contact us
Product Categories
API R&D pipeline
Dolastatin 10 Key fragments
Cangrelor key intermediate
Lifitegrast key intermediate
Ticagrelor key intermediate
Indacaterol key intermediate
Sitagliptin key intermediate
Ibrutinib key intermediate
Lesinurad key intermediate
Core Molecular Skeleton
Characteristic building blocks
Specialty chemicals
Original brand reagents
Position:
Home
> News
We Gruechem have established project cooperation with Novozymes
2021-07-08
PD-1 / PDL-1抑制剂在癌症免疫治疗中的当前和未来展望(转自药渡网)
2021-05-14
Innovative drug development choices: stand alone or flourish?
2021-04-24